إعلان
إعلان
IMNM
Immunome, Inc.
21.09
USDبرعاية
+0.64
+3.11%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
21.21
+0.13
+0.61%
تقارير أرباح IMNM
النسبة الإيجابية المفاجئة
IMNM تفوق 7 من 20 آخر التقديرات.
35%
التقرير التالي
بيانات التقرير القادم
١٧ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$340.00K
/-$0.61
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-6.15%
التغير الضمني من Q4 24 (Revenue/ EPS)
-87.58%
/-52.34%
Immunome, Inc. earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, IMNM reported earnings of -0.65 USD per share (EPS) for Q3 25, missing the estimate of -0.58 USD, resulting in a -10.98% surprise. Revenue reached --, compared to an expected 816.00 ألف, with a -100.00% difference. The market reacted with a -1.68% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 المحللين forecast an EPS of -0.61 USD, with revenue projected to reach 340.00 ألف USD, implying an نقصان of -6.15% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Immunome, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Immunome, Inc. reported EPS of -$0.65, missing estimates by -10.98%, and revenue of $0.00, -100% below expectations.
How did the market react to Immunome, Inc.'s Q3 2025 earnings?
The stock price moved down -1.68%, changed from $15.50 before the earnings release to $15.24 the day after.
When is Immunome, Inc. expected to report next?
The next earning report is scheduled for ١٧ مارس ٢٠٢٦.
What are the forecasts for Immunome, Inc.'s next earnings report?
Based on 15
المحللين, Immunome, Inc. is expected to report EPS of -$0.61 and revenue of $340.00K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان